http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011119639-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 |
| filingDate | 2009-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2011119639-A |
| titleOfInvention | COMBINATION OF INSULIN AND AGONIST GLP-1 |
| abstract | 1. A drug comprising at least one insulin and at least one GLP-1 agonist, the drug is formulated and / or formulated so that it includes insulin and a GLP-1 agonist, each in a predetermined amount , and can be administered in a dose adapted to the individual needs of the patient. 2. The medicine according to claim 1 for regulating the concentration of fasting blood glucose after eating and / or after absorption in patients with diabetes. The drug according to claim 1 or 2 for improving glucose tolerance. 4. The drug according to claim 1 or 2 for the prevention of hypoglycemia. 5. The drug according to claim 1 or 2 for preventing the loss of function of pancreatic β-cells. The drug according to claim 1 or 2 for weight loss and / or to prevent weight gain. The medicament according to claim 1 or 2, comprising a first pharmaceutical composition and a second pharmaceutical composition, and optionally at least one additional pharmaceutical composition, each of which includes at least one insulin and at least one GLP agonist -1 and contains at least one insulin and / or at least one GLP-1 agonist in different weight amounts with respect to the total weight of the composition. The medicament according to claim 7, weight amounts of at least one insulin and at least one GLP-1 agonist in the first pharmaceutical composition, in the second pharmaceutical composition, and, where used, in at least one additional pharmaceutical the compositions are selected so that the pharmaceutical compositions include various relationships |
| priorityDate | 2008-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.